<DOC>
	<DOCNO>NCT01820143</DOCNO>
	<brief_summary>The objective study ( ) evaluate pharmacokinetics evaluate compare pharmacodynamics ilaprazole esomeprazole follow single dose ( Day 1 ) daily ( QD ) administration 5 consecutive day 10-mg , 20-mg , 40-mg ilaprazole tablet 40-mg esomeprazole tablet ; ( b ) evaluate safety 10-mg , 20-mg , 40-mg ilaprazole tablet follow QD oral administration 5 consecutive day ; ( c ) characterize plasma gastrin concentration profile Day 1 Day 5 follow QD oral administration 10-mg , 20-mg , 40-mg ilaprazole 40-mg esomeprazole tablet 5 consecutive day .</brief_summary>
	<brief_title>Study Evaluate Pharmacokinetics , Pharmacodynamics Safety</brief_title>
	<detailed_description />
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Prior studyspecific procedure perform , subject voluntarily sign approve informed consent/PIPEDA authorization form fully explain question answer . The subject 18 55 year , inclusive , generally good health . Pregnancy test result female negative order enter remain study . A serum pregnancy test perform female Screening , Day 1 period , Day 6 Period 4 , subject prematurely discontinue . Results must negative order study drug administer . Female subject use , agree continue use , doublebarrier method birth control . Oral , patch , implant , injectable contraceptive accept 1 method subject take great 2 month Screening Visit . Subjects bilateral tubal ligation , hysterectomy , bilateral oophorectomy minimum 6 month , surgical sterilization partner ( vasectomy 6 month minimum ) , postmenopausal ( define absence menses 2 year absence menses 12 month folliclestimulating hormone [ FSH ] level &gt; 40 IU/L ) require use birth control . Subject negative breath test result H pylorus prior enrollment . At Screening Visit , subject body mass index ( BMI ) within range 18 30 kg/m2 , determine follow calculation . Subject general good health evidence medical history , complete physical examination , ECG without clinically significant abnormality . Subject current evidence cardiovascular , central nervous system , hepatic , hematopoietic , renal , metabolic dysfunction ; serious allergy , asthma , history significant sensitivity drug ; lactose intolerance would contraindicate take ilaprazole esomeprazole would interfere conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2005</verification_date>
</DOC>